Company Profile
SOLIGENIX Stock Price, News & Analysis
- Ticker:
- SNGX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.36 USD (-2.53%)
Close
Last updated: July 27, 2026
11.1M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, SNGX closed down 2.53% at $0.3619. No new same-company headline was identified in the current news window.
Company overview
Business overview
Soligenix is a specialty biotechnology company focused on inflammatory diseases, biodefense, and orphan indications. Its story reflects a broad but still narrow small-cap pipeline targeting areas with high unmet need.
Geographic Base and Sector Classification
Soligenix is headquartered in the United States and listed on NASDAQ. It sits in small-cap specialty biopharma.
Business Model Characteristics
The company depends on clinical data, regulatory optionality, and capital discipline across multiple development programs. Investors usually focus on data updates and whether the company can maintain enough runway.
Position Within the Biotechnology Landscape
Soligenix occupies a niche orphan/inflammation position within biotech. Its stock is sensitive to whether the pipeline can create even one durable catalyst path.
Future catalysts
SOLIGENIX's catalyst setup now looks most tied to its latest development priorities. What gives this more shape is May 8, 2026 Skip to content soligenix-logo Soligenix Main Menu About Soligenix Show submenu Corporate Overview Scientific Advisory Boards Show submenu Scientific Advisory Board.... That setup makes the next update more important than the headline financials themselves.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
ACST · Source: Acasti Pharma
- 02
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of SOLIGENIX (SNGX)?
SOLIGENIX (SNGX) most recently closed at 0.36 USD, a -2.53% move versus the previous session.
What is the market cap of SOLIGENIX (SNGX)?
SOLIGENIX currently has a market capitalization of 11.1M USD on BioPharmSignal.
What does SOLIGENIX do?
Soligenix is a specialty biotechnology company focused on inflammatory diseases, biodefense, and orphan indications. Its story reflects a broad but still narrow small-cap pipeline targeting areas with high unmet need.
On which exchange is SNGX stock listed?
SOLIGENIX (SNGX) is associated with NASDAQ, United States, Biopharma.
What is Soligenix?
SOLIGENIX's catalyst setup now looks most tied to its latest development priorities.
Which conditions is SOLIGENIX targeting with Soligenix?
SOLIGENIX's catalyst setup now looks most tied to its latest development priorities.
How does SOLIGENIX describe recent progress with Soligenix?
SOLIGENIX's catalyst setup now looks most tied to its latest development priorities.
What is What?
What gives this more shape is May 8, 2026 Skip to content soligenix-logo Soligenix Main Menu About Soligenix Show submenu Corporate Overview Scientific Advisory Boards Show submenu Scientific Advisory Board....